Cryosite Limited (ASX:CTE)
1.100
+0.040 (3.77%)
Feb 4, 2026, 11:07 AM AEST
Cryosite Revenue
In the fiscal year ending June 30, 2025, Cryosite had annual revenue of 14.12M AUD with 11.93% growth. Cryosite had revenue of 7.48M in the half year ending June 30, 2025, with 20.33% growth.
Revenue
14.12M
Revenue Growth
+11.93%
P/S Ratio
3.80
Revenue / Employee
564.64K
Employees
25
Market Cap
53.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 14.12M | 1.50M | 11.93% |
| Jun 30, 2024 | 12.61M | 677.00K | 5.67% |
| Jun 30, 2023 | 11.94M | 178.00K | 1.51% |
| Jun 30, 2022 | 11.76M | 1.73M | 17.29% |
| Jun 30, 2021 | 10.02M | 1.10M | 12.38% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healius | 1.34B |
| Australian Clinical Labs | 741.27M |
| Integral Diagnostics | 627.22M |
| Monash IVF Group | 271.92M |
| Genetic Signatures | 19.75M |
| Microba Life Sciences | 15.67M |
| Genetic Technologies | 9.17M |
| Rhythm Biosciences | 3.19M |